Size of the ablation technology market worth US$18.09 billion at

Pune, Aug. 30, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the Global ablation technology market it is expected that the clock $18.09 billion by 2030 and grow at a CAGR of 8.9% during the forecast period. Due to the increasing prevalence of cardiovascular diseases and the availability of technologically advanced products coupled with an increasing demand for minimally invasive procedures. This exclusive information is published by Growth Plus Reports in its report entitled “Ablation technology market – Global Outlook and Forecast Period 2022-2030 »

Request a sample copy of the research report:

Market factors

Rising prevalence of cancer and cardiovascular disease (CVD) and increasing geriatric population are the major factors driving the growth of the global ablation market. Benefits such as rapid recovery, lower risk of infection compared to traditional surgery, shorter hospital stays, decreased discomfort, and smaller incisions have enabled greater demand for minimally invasive procedures. or non-invasive. The commercial introduction of next-generation technologies is also paving the way for market growth. For example, in January 2021, Medtronic Inc. received FDA approval for the DiamondTempTM Ablation Catheter, for the treatment of abnormal heart rhythm. This device has an improved imaging system, is more portable and has better accuracy.

The global ablation technology market has been analyzed from four angles: product, application, end user and region.

Extracts from ‘By Product Segmentation’

Based on product type, the global ablation technology market is categorized into:

  • Radio frequency
  • Cryoablation
  • Laser
  • Ultrasound
  • Microwave
  • Electric
  • Hydrothermal

The radio frequency segment dominated the global market with the largest market share in 2021, followed by cryoablation. A growing trend in the use of radiofrequency ablation technology in the treatment of a large number of conditions, such as heart disease, cancer, chronic pain and ophthalmic diseases, has been observed in recent years. . Similarly, cryoablation is used to treat a variety of conditions, such as skin abnormalities, atypical moles, warts, skin tags, actinic keratosis (precancerous skin growths), arrhythmia (frequency and rhythm abnormal heart) and cancerous tumors (such as those of the skin, liver, kidney, bone, lung, prostate and breast).

Excerpts from ‘By Segmentation of applications’

Based on Application, the global ablation technology market is segmented into:

  • Cancer treatment
  • Cardiovascular treatment
  • Gynecological treatment
  • Plastic surgery
  • pain management
  • Ophthalmological
  • Urological
  • Orthopedic
  • Others

The cardiovascular segment dominated the market with the largest market share in 2021. Cancer treatment is another important application area for ablation technologies. According to the American Cancer Society in 2021 there will be approximately 1.9 million new cases of cancer in the United States and 608.57 cancer deaths. Many solid tumors are increasingly being treated with ablation procedures, with proven increased efficacy and safety. Thus, the demand for highly safe and effective technologies for the treatment of cancer and the growing awareness of ablation procedures are expected to drive the growth of the segment.

Get a personalized report according to your needs:

Excerpts from ‘Segmentation by region’

Based on region, the global ablation technology market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

North America led the global ablation technology market in 2021, followed by Europe. The Asia-Pacific market is expected to grow at the fastest CAGR over the forecast period. North America’s large share in the global ablation technologies market can be attributed to the high demand for non-invasive or minimally invasive procedures, as well as an increase in the prevalence of cancer and cardiovascular diseases. There is a high level of awareness of ablation technology in the region, along with the presence of developed healthcare infrastructure, high healthcare expenditures and rapid adoption of new treatment methods. For example, in 2019 the US FDA approved Abbott Laboratories’ TactiCath contact force ablation catheter for the treatment of atrial fibrillation. While Asia-Pacific’s growth can be attributed to the increasing prevalence of cardiovascular disease and cancer, government initiatives in the region are raising awareness of ablation techniques. The increase in the geriatric population in the region is also a key growth driver. According to the WHO, the proportion of people aged 60 and over is estimated to be 9.8% in 2017 in Southeast Asia and is expected to increase from 13.7% in 2030 to 20.3% in 2050 .

Excerpts from “Competitive Landscape”

Some of the major players operating in the global ablation technology market are

  • Medtronic plc
  • AngioDynamics Inc.
  • Abbott Laboratories Inc.
  • Boston Scientific Society
  • Johnson & Johnson (Ethicon Inc.)
  • CONMED Company
  • Bausch & Lomb Incorporated
  • Biotronik SE & Co. KG
  • Atricure Inc.
  • Varian Medical Systems
  • Olympus Society
  • Dornier MedTech
  • Among others


    1. Market ecosystem
    2. Schedule under study
      1. Historical years – 2020
      2. Base year – 2021
      3. Planned years – 2022 to 2030
    3. Currency used in the report
    1. Research approach
    2. Data collection methodology
    3. Information source
      1. Secondary sources
      2. Primary sources
    4. Market estimation approach
      1. From bottom to top
      2. From top to bottom
    5. Market Forecast Model
    6. Limits and assumptions
    1. Current market trend (COVID-19 outlook)
    2. Key players and competitive positioning (2021)
    1. Drivers
    2. Constraints/Challenges
    3. Opportunities
    1. Radio frequency
    2. Cryoablation
    3. Laser
    4. Ultrasound
    5. Microwave
    6. Electric
    7. Hydrothermal
    1. Cancer
    2. Cardiovascular
    3. Gynecological
    4. Cosmetic
    5. pain management
    6. Ophthalmological
    7. Urological
    8. Orthopedic
    9. Others
    1. Hospitals
    2. Ambulatory surgery centers
    3. Medical spas
    4. Others

TOC Continued…


  • Fueled by free analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative information at segment and sub-segment level
  • Trends and perspectives of the impact of Covid 19
  • Granular information at global/regional/country level
  • In-depth insights into market dynamics (drivers, restraints, opportunities) and business environment
  • Global coverage of the competitive landscape
  • Winning imperatives
  • Comprehensive coverage of “strategic developments” recorded by major market players


  • Distributor Landscape Assessment
  • Pricing information
  • Customer evaluation
  • Analysis of investments and initiatives
  • ‘Company Profile’ of key players

Talk to our expert:

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge services company. We are proud members of the EPhMRA (European Pharmaceutical Marketing Research Association).

The Growth Plus portfolio of services leverages our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable solutions and breakthroughs that set them up for future growth and success.

We have been recognized by the prestigious CEO Magazine as “The Most Innovative Market Research Company in the Healthcare Market of 2020.

Related Article

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button